世界のオルガノイド市場2020年ｰ2030年：種類別（胃、腸、肝臓、膵臓、肺、脳、腎臓、その他）、用途別、由来別

• 英文タイトル：Organoids Market (Type: Stomach, Intestine, Liver, Pancreas, Lung, Brain, Kidney, and Others; Application: Developmental Biology, Disease Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity and Efficacy Testing, Drug Discovery & Personalized Medicine, and Others; and Source: Pluripotent Stem Cells [hIPSCs] and Organ-speci?c Adult Stem Cells [ASCs]) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030

• レポートコード：MRC2103G103 • 出版社/出版日：Transparency Market Research / 2020年11月9日 • レポート形態：英文、PDF、190ページ • 納品方法：Eメール • 産業分類：バイオ

• 販売価格（消費税別）

Single User	￥857,660 (USD5,795)	▷ お問い合わせ
Site Licence	￥1,301,660 (USD8,795)	▷ お問い合わせ
Enterprisewide Licence	￥1,745,660 (USD11,795)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

Transparency Market Research社の本調査資料では、世界のオルガノイド市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別（胃、腸、肝臓、膵臓、肺）分析、用途別分析、由来別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成でまとめております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・キーインサイト ・オルガノイドの世界市場規模：種類別（胃、腸、肝臓、膵臓、肺） ・オルガノイドの世界市場規模：用途別 ・オルガノイドの世界市場規模：由来別 ・オルガノイドの世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況

Organoids Market – Scope of the Report

TMR’s report on the global organoids market studies the past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2020 to 2030. The report provides the overall revenue of the global organoids market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global organoids market for the forecast period.

The report has been prepared after an extensive research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global organoids market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts also employed a combination of top-down and bottom-up approaches to study various phenomena in the global organoids market.

The report comprises an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study. Additionally, the report sheds light on changing competitive dynamics in the global organoids market. These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global organoids market. The next section of the global organoids market report highlights the USPs, which include increase in incidence & prevalence of diseases, including infectious and other chronic disease, adoption of organoids in the research & development, technological advancements, and COVID-19 pandemic impact on the global organoids market.

The report delves into the competition landscape of the global organoids market. Key players operating in the global organoids market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global organoids market report.

Key Questions Answered in Organoids Market Report

What is the sales/revenue generated by the global organoids market across all regions during the forecast period?
What are the key trends in the global organoids market?
What are the major drivers, restraints, and opportunities in the global market?
Which region is set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2030, and which type, application, and source segment will expand at the fastest CAGR during the forecast period?
Organoids Market – Research Objectives and Research Approach

The comprehensive report on the global organoids market begins with an overview of the market, followed by the scope and objectives of the study. Following this, the report provides detailed explanation of the objectives of the study and healthcare compliances laid down by accredited agencies in the purview of research in the global organoids market. It is followed by market introduction, market dynamics, and an overview of the global organoids market, which includes TMR analysis of market drivers, restraints, and trends affecting the growth of the market. Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the global organoids market. The next section of the global organoids market report highlights the USPs, which includes increase in incidence and prevalence of diseases, including infectious and other chronic conditions, adoption of organoids in the research & development, technological advancements, and COVID-19 pandemic impact on the global organoids market.

For reading comprehensibility, the report has been compiled in a chapter-wise layout with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the compilation. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of market shares of key segments in the past and at the end of the forecast period.

Revenue generated by key product manufacturers has been mapped to ascertain the size of the global organoids market in terms of value. The forecast presented here assesses the total revenue generated in the global organoids market. In order to provide an accurate forecast, we initiated by sizing up the current organoids market with the help of the parent market.

The report analyzes the global organoids market in terms of type, application, source, and region. Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2030 has been provided. These valuable insights would help market stakeholders in making informed business decisions for investments in the global organoids market.

レポート目次

---

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Organoids Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Organoids Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Regulatory Scenario by Region/globally
5.2. Disease Prevalence & Incidence Rate globally with key countries
5.3. Technological Advancements
5.4. COVID-19 Pandemic Impact on Global Organoids Market
6. Global Organoids Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Organoids Market Value Forecast, by Type,2018–2030
6.3.1. Stomach
6.3.2. Intestine
6.3.3. Liver
6.3.4. Pancreas
6.3.5. Lung
6.3.6. Brain
6.3.7. Kidney
6.3.8. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Organoids Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Organoids Market Value Forecast, by Application, 2018–2030
7.3.1. Developmental Biology
7.3.2. Disease Pathology of Infectious Disease
7.3.3. Regenerative Medicine
7.3.4. Drug Toxicity & Efficacy Testing
7.3.5. Drug Discovery & Personalized Medicine
7.3.6. Others
7.4. Global Organoids Market Attractiveness Analysis, by Application
8. Global Organoids Market Analysis and Forecast, by Source
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Organoids Market Value Forecast, by Source, 2018–2030
8.3.1. Pluripotent Stem Cells (hIPSCs)
8.3.2. Organ-speci?c Adult Stem Cells (ASCs)
8.4. Global Organoids Market Attractiveness Analysis, by Source
9. Global Organoids Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Organoids Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Organoids Market Attractiveness Analysis, by Region
10. North America Organoids Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Organoids Market Value Forecast, by Type,2018–2030
10.2.1. Stomach
10.2.2. Intestine
10.2.3. Liver
10.2.4. Pancreas
10.2.5. Lung
10.2.6. Brain
10.2.7. Kidney
10.2.8. Others
10.3. North America Organoids Market Value Forecast, by Application, 2018–2030
10.3.1. Developmental Biology
10.3.2. Disease Pathology of Infectious Disease
10.3.3. Regenerative Medicine
10.3.4. Drug Toxicity & Efficacy Testing
10.3.5. Drug Discovery & Personalized Medicine
10.3.6. Others
10.4. North America Organoids Market Value Forecast, by Source, 2018–2030
10.4.1. Pluripotent Stem Cells (hIPSCs)
10.4.2. Organ-speci?c Adult Stem Cells (ASCs)
10.5. North America Organoids Market Value Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Organoids Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By Source
10.6.4. By Country
11. Europe Organoids Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Organoids Market Value Forecast, by Type,2018–2030
11.2.1. Stomach
11.2.2. Intestine
11.2.3. Liver
11.2.4. Pancreas
11.2.5. Lung
11.2.6. Brain
11.2.7. Kidney
11.2.8. Others
11.3. Europe Organoids Market Value Forecast, by Application, 2018–2030
11.3.1. Developmental Biology
11.3.2. Disease Pathology of Infectious Disease
11.3.3. Regenerative Medicine
11.3.4. Drug Toxicity & Efficacy Testing
11.3.5. Drug Discovery & Personalized Medicine
11.3.6. Others
11.4. Europe Organoids Market Value Forecast, by Source, 2018–2030
11.4.1. Pluripotent Stem Cells (hIPSCs)
11.4.2. Organ-speci?c Adult Stem Cells (ASCs)
11.5. Europe Organoids Market Value Forecast, by Country/Sub-region, 2018–2030
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Organoids Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By Source
11.6.4. By Country/Sub-region
12. Asia Pacific Organoids Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Organoids Market Value Forecast, by Type,2018–2030
12.2.1. Stomach
12.2.2. Intestine
12.2.3. Liver
12.2.4. Pancreas
12.2.5. Lung
12.2.6. Brain
12.2.7. Kidney
12.2.8. Others
12.3. Asia Pacific Organoids Market Value Forecast, by Application, 2018–2030
12.3.1. Developmental Biology
12.3.2. Disease Pathology of Infectious Disease
12.3.3. Regenerative Medicine
12.3.4. Drug Toxicity & Efficacy Testing
12.3.5. Drug Discovery & Personalized Medicine
12.3.6. Others
12.4. Asia Pacific Organoids Market Value Forecast, by Source, 2018–2030
12.4.1. Pluripotent Stem Cells (hIPSCs)
12.4.2. Organ-speci?c Adult Stem Cells (ASCs)
12.5. Asia Pacific Organoids Market Value Forecast, by Country/Sub-region, 2018–2030
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Organoids Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By Source
12.6.4. By Country/Sub-region
13. Latin America Organoids Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Organoids Market Value Forecast, by Type,2018–2030
13.2.1. Stomach
13.2.2. Intestine
13.2.3. Liver
13.2.4. Pancreas
13.2.5. Lung
13.2.6. Brain
13.2.7. Kidney
13.2.8. Others
13.3. Latin America Organoids Market Value Forecast, by Application, 2018–2030
13.3.1. Developmental Biology
13.3.2. Disease Pathology of Infectious Disease
13.3.3. Regenerative Medicine
13.3.4. Drug Toxicity & Efficacy Testing
13.3.5. Drug Discovery & Personalized Medicine
13.3.6. Others
13.4. Latin America Organoids Market Value Forecast, by Source, 2018–2030
13.4.1. Pluripotent Stem Cells (hIPSCs)
13.4.2. Organ-speci?c Adult Stem Cells (ASCs)
13.5. Latin America Organoids Market Value Forecast, by Country/Sub-region, 2018–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Organoids Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By Source
13.6.4. By Country/Sub-region
14. Middle East & Africa Organoids Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Organoids Market Value Forecast, by Type,2018–2030
14.2.1. Stomach
14.2.2. Intestine
14.2.3. Liver
14.2.4. Pancreas
14.2.5. Lung
14.2.6. Brain
14.2.7. Kidney
14.2.8. Others
14.3. Middle East & Africa Organoids Market Value Forecast, by Application, 2018–2030
14.3.1. Developmental Biology
14.3.2. Disease Pathology of Infectious Disease
14.3.3. Regenerative Medicine
14.3.4. Drug Toxicity & Efficacy Testing
14.3.5. Drug Discovery & Personalized Medicine
14.3.6. Others
14.4. Middle East & Africa Organoids Market Value Forecast, by Source, 2018–2030
14.4.1. Pluripotent Stem Cells (hIPSCs)
14.4.2. Organ-speci?c Adult Stem Cells (ASCs)
14.5. Middle East & Africa Organoids Market Value Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Organoids Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By Source
14.6.4. By Country/Sub-region
15. Competitive Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1.STEMCELL Technologies, Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. Strategic Overview
15.2.1.4. SWOT Analysis
15.2.2.Cellesce Ltd
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. Strategic Overview
15.2.2.4. SWOT Analysis
15.2.3. Hubrecht Organoid Technology
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. Strategic Overview
15.2.3.4. SWOT Analysis
15.2.4.Definigen
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. Strategic Overview
15.2.4.4. SWOT Analysis
15.2.5.3Dnamics, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. Strategic Overview
15.2.5.4. SWOT Analysis
15.2.6.Organoid Therapeutics
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. Strategic Overview
15.2.6.4. SWOT Analysis
15.2.7. PeproTech, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. Strategic Overview
15.2.7.4. SWOT Analysis
15.2.8. Thermo Fisher Scientific
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Financial Overview
15.2.8.3. Product Portfolio
15.2.8.4. Strategic Overview
15.2.8.5. SWOT Analysis
15.2.9.Corning Incorporated (Life Sciences)
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Financial Overview
15.2.9.3. Product Portfolio
15.2.9.4. Strategic Overview
15.2.9.5. SWOT Analysis
15.2.10. Merck KGgA
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Financial Overview
15.2.10.3. Product Portfolio
15.2.10.4. Strategic Overview
15.2.10.5. SWOT Analysis

List of Tables

Table 01: Global Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 02: Global Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 03: Global Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 04: Global Organoids Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 05: North America Organoids Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 06: North America Organoids Market Value Forecast, by Type, 2018–2030
Table 07: North America Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 08: North America Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 09: Europe Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 10: Europe Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 11: Europe Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 12: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 13: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 14: Asia Pacific Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 15: Latin America Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 16: Latin America Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 17: Latin America Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030
Table 18: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Type, 2018–2030
Table 19: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 20: Middle East & Africa Organoids Market Value (US$ Mn) Forecast, by Source, 2018–2030

---